rokotteet
http://www.yso.fi/onto/yso/p15634
Liittyvät julkaisut ja muut tuotokset
- Predicting COVID‐19 booster vaccine intentions (2022) Hagger, Martin S.; et al.; A1; OA
- Säännöllinen liikunta tehostaa todennäköisesti koronarokotteen vaikutusta (2022) Hautala, Arto; D1; OA
- The Vaccination Concerns in COVID-19 Scale (VaCCS) : Development and validation (2022) Hamilton, Kyra; et al.; A1; OA
- A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates (2020) Stone, V. M.; et al.; A1; OA
- Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine (2020) Hankaniemi, Minna M.; et al.; A1; OA
- A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine (2019) Hankaniemi, Minna M.; et al.; A1; OA
- Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine (2019) Hankaniemi, Minna M.; et al.; A1; OA
- Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model (2017) Hankaniemi, Minna M.; et al.; A1
- Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells (1999) Nedeljkovic, Jasminka; et al.; B1